FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4372334222> ?p ?o ?g. }

• W4372334222 abstract "Novel thiazolidine-2,4-diones have been developed and estimated as conjoint inhibitors of EGFRT790M and VEGFR-2 against HCT-116, MCF-7, A549, and HepG2 cells. Compounds 6a, 6b, and 6c were known to be the dominant advantageous congeners against HCT116 (IC50 = 15.22, 8.65, and 8.80 µM), A549 (IC50 = 7.10, 6.55, and 8.11 µM), MCF-7 (IC50 = 14.56, 6.65, and 7.09 µM) and HepG2 (IC50 = 11.90, 5.35, and 5.60 µM) mass cell lines, correspondingly. Although compounds 6a, 6b, and 6c disclosed poorer effects than sorafenib (IC50 = 4.00, 4.04, 5.58, and 5.05 µM) against the tested cell sets, congeners 6b and 6c demonstrated higher actions than erlotinib (IC50 = 7.73, 5.49, 8.20, and 13.91 µM) against HCT116, MCF-7 and HepG2 cells, yet lesser performance on A549 cells. The hugely effective derivatives 4e–i and 6a–c were inspected versus VERO normal cell strains. Compounds 6b, 6c, 6a, and 4i were found to be the most effective derivatives, which suppressed VEGFR-2 by IC50 = 0.85, 0.90, 1.50, and 1.80 µM, respectively. Moreover, compounds 6b, 6a, 6c, and 6i could interfere with the EGFRT790M performing strongest effects with IC50 = 0.30, 0.35, 0.50, and 1.00 µM, respectively. What is more, 6a, 6b, and 6c represented satisfactory in silico computed ADMET profile." @default.
• W4372334222 created "2023-05-07" @default.
• W4372334222 creator A5004935872 @default.
• W4372334222 creator A5007843479 @default.
• W4372334222 creator A5018764734 @default.
• W4372334222 creator A5021745382 @default.
• W4372334222 creator A5022320601 @default.
• W4372334222 creator A5034703492 @default.
• W4372334222 creator A5066270766 @default.
• W4372334222 creator A5067338844 @default.
• W4372334222 creator A5081083092 @default.
• W4372334222 date "2023-05-05" @default.
• W4372334222 modified "2023-09-29" @default.
• W4372334222 title "Design, synthesis, and docking of novel thiazolidine‐2,4‐dione multitarget scaffold as new approach for cancer treatment" @default.
• W4372334222 cites W1416958482 @default.
• W4372334222 cites W1608710587 @default.
• W4372334222 cites W1688725836 @default.
• W4372334222 cites W1964596754 @default.
• W4372334222 cites W1973035839 @default.
• W4372334222 cites W1979449084 @default.
• W4372334222 cites W1992905076 @default.
• W4372334222 cites W1999845081 @default.
• W4372334222 cites W2009867031 @default.
• W4372334222 cites W2018711732 @default.
• W4372334222 cites W2037394376 @default.
• W4372334222 cites W2056259571 @default.
• W4372334222 cites W2063302127 @default.
• W4372334222 cites W2066629358 @default.
• W4372334222 cites W2071635244 @default.
• W4372334222 cites W2077218183 @default.
• W4372334222 cites W2085165769 @default.
• W4372334222 cites W2114918609 @default.
• W4372334222 cites W2151178480 @default.
• W4372334222 cites W2156373035 @default.
• W4372334222 cites W2177929699 @default.
• W4372334222 cites W2418046358 @default.
• W4372334222 cites W2593093801 @default.
• W4372334222 cites W2734066598 @default.
• W4372334222 cites W2750145485 @default.
• W4372334222 cites W2940507061 @default.
• W4372334222 cites W2964471257 @default.
• W4372334222 cites W2981810096 @default.
• W4372334222 cites W3037626323 @default.
• W4372334222 cites W3039947924 @default.
• W4372334222 cites W3094019790 @default.
• W4372334222 cites W3095777980 @default.
• W4372334222 cites W3099076257 @default.
• W4372334222 cites W3122976576 @default.
• W4372334222 cites W3125341679 @default.
• W4372334222 cites W3183173575 @default.
• W4372334222 cites W3193974056 @default.
• W4372334222 cites W3204493825 @default.
• W4372334222 cites W3217001088 @default.
• W4372334222 cites W4225325549 @default.
• W4372334222 cites W4248107770 @default.
• W4372334222 cites W4284882937 @default.
• W4372334222 cites W4293795465 @default.
• W4372334222 cites W4304165768 @default.
• W4372334222 cites W4309438082 @default.
• W4372334222 cites W4322748147 @default.
• W4372334222 doi "https://doi.org/10.1002/ardp.202300137" @default.
• W4372334222 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37147779" @default.
• W4372334222 hasPublicationYear "2023" @default.
• W4372334222 type Work @default.
• W4372334222 citedByCount "4" @default.
• W4372334222 countsByYear W43723342222023 @default.
• W4372334222 crossrefType "journal-article" @default.
• W4372334222 hasAuthorship W4372334222A5004935872 @default.
• W4372334222 hasAuthorship W4372334222A5007843479 @default.
• W4372334222 hasAuthorship W4372334222A5018764734 @default.
• W4372334222 hasAuthorship W4372334222A5021745382 @default.
• W4372334222 hasAuthorship W4372334222A5022320601 @default.
• W4372334222 hasAuthorship W4372334222A5034703492 @default.
• W4372334222 hasAuthorship W4372334222A5066270766 @default.
• W4372334222 hasAuthorship W4372334222A5067338844 @default.
• W4372334222 hasAuthorship W4372334222A5081083092 @default.
• W4372334222 hasConcept C104317684 @default.
• W4372334222 hasConcept C159110408 @default.
• W4372334222 hasConcept C170493617 @default.
• W4372334222 hasConcept C185592680 @default.
• W4372334222 hasConcept C202751555 @default.
• W4372334222 hasConcept C21951064 @default.
• W4372334222 hasConcept C2775905019 @default.
• W4372334222 hasConcept C2776590680 @default.
• W4372334222 hasConcept C2777752497 @default.
• W4372334222 hasConcept C2778019345 @default.
• W4372334222 hasConcept C2778087573 @default.
• W4372334222 hasConcept C2778695046 @default.
• W4372334222 hasConcept C2779438470 @default.
• W4372334222 hasConcept C41685203 @default.
• W4372334222 hasConcept C502942594 @default.
• W4372334222 hasConcept C54355233 @default.
• W4372334222 hasConcept C55493867 @default.
• W4372334222 hasConcept C71240020 @default.
• W4372334222 hasConcept C71924100 @default.
• W4372334222 hasConcept C81729549 @default.
• W4372334222 hasConcept C81885089 @default.
• W4372334222 hasConcept C86803240 @default.
• W4372334222 hasConcept C98274493 @default.
• W4372334222 hasConceptScore W4372334222C104317684 @default.

• next